Gmo International Valuation
| GMOUX Fund | USD 24.59 0.11 0.45% |
At this time, the entity appears to be fairly valued. Gmo International Equity retains a regular Real Value of $24.84 per share. The prevalent price of the fund is $24.59. We determine the value of Gmo International Equity from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Fairly Valued
Today
Please note that Gmo International's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Gmo International Equity retains a regular Real Value of $24.84 per share. The prevalent price of the fund is $24.59. We determine the value of Gmo International Equity from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GMO Mutual Fund. However, Gmo International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.59 | Real 24.84 | Hype 24.59 |
The intrinsic value of Gmo International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo International Equity helps investors to forecast how GMO mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo International more accurately as focusing exclusively on Gmo International's fundamentals will not take into account other important factors: About Gmo International Valuation
Our relative valuation model uses a comparative analysis of Gmo International. We calculate exposure to Gmo International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gmo International's related companies.The adviser seeks to achieve the funds investment objective by investing the funds assets primarily in non-U.S. developed market equities. Under normal circumstances, the fund invests directly and indirectly at least 80 percent of its assets in equities. It also may invest in U.S. Treasury fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.
Other Information on Investing in GMO Mutual Fund
Gmo International financial ratios help investors to determine whether GMO Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GMO with respect to the benefits of owning Gmo International security.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |